BMRN BIOMARIN PHARMACEUTICAL INC
2026Q1 · CUSIP 09061G101 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
552
Δ holders QoQ
+15
Breadth percentile
Top 21%
Whale holders
216
Δ whales
-7
Inst. holding value
$10.3B
New positions
90
Closed positions
75
Price momentum (1Q)
-17.1%
Put / Call
10/15
Breadth history (34 quarters)
Past Lit Events & Aftermath 11 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q1 | Top 4% | -3.5% | -8.3% |
| 2023Q4 | Top 18% | -12.6% | +4.5% |
| 2022Q4 | Top 15% | -14.0% | -17.0% |
| 2022Q3 | Top 12% | +26.2% | +7.1% |
| 2021Q4 | Top 10% | -15.7% | +0.3% |
| 2020Q4 | Top 14% | -8.9% | -11.6% |
| 2020Q2 | Top 11% | -35.1% | -28.2% |
| 2020Q1 | Top 2% | +25.3% | -18.7% |
Options Sentiment
Put holders
10
QoQ: -8
Call holders
15
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
42.9
EPS (TTM)
$1.39
EPS YoY
-48.5%
Revenue (TTM)
$3.2B
Revenue YoY
+9.9%
Net margin
8.3%
ROE
4.3%
Debt ratio
27.7%
FCF (TTM)
$767M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.